Lista de obras -

Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancer

artículo científico publicado en 2012

Advancing women's cancer care. Report from the 37th Annual Meeting of the Society of Gynecologic Oncologists, Palm Springs, Calif., USA, March 22-26, 2006.

artículo científico publicado en 2006

Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer

scientific article published on 01 September 2002

Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis

artículo científico publicado en 2007

BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines

artículo científico publicado el 1 de junio de 2012

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma

artículo científico publicado en 2010

Basic and clinical significance of IGF-I-induced signatures in cancer

artículo científico publicado en 2010

Carboplatin hypersensitivity: evaluation and successful desensitization protocol

artículo científico publicado en 2014

Combination of endometrial thickness and time since menopause in predicting endometrial cancer in women with postmenopausal bleeding.

artículo científico publicado en 2004

Contribution of sonographic measurement of ovarian volume to diagnosing ovarian tumors in postmenopausal women

artículo científico publicado en 2004

Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.

artículo científico publicado en 2016

Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma

artículo científico publicado en 2009

Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action

artículo científico publicado en 2018

Granulocytic sarcoma presenting as tumors of the cervix

artículo científico publicado en 2005

High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer-A Phase 2 Cohort Study

artículo científico publicado en 2016

IGF-1 and BRCA1 signalling pathways in familial cancer

artículo científico

IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer

artículo científico publicado en 2014

IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer

artículo científico publicado en 2013

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

artículo científico publicado en 2008

Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways

artículo científico publicado en 2016

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer

artículo científico publicado en 2005

Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells.

artículo científico publicado en 2011

Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines ⬇️

artículo científico publicado el 3 de febrero de 2011

Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners

artículo científico publicado en 2013

Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia ⬇️

artículo científico publicado el 11 de noviembre de 2010

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway

artículo científico publicado en 2018

Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2.

artículo científico publicado en 2012

Preoperative clinical and radiological features of metastatic ovarian tumors.

artículo científico publicado en 2013

Proliferative and signaling activities of insulin analogues in endometrial cancer cells

artículo científico publicado en 2015

Sarcoma post-embolization for presumed uterine fibroids

scientific article published on 22 October 2007

Screening for cervical neoplasia: A community‐based trial comparing Pap staining, human papilloma virus testing, and the new bi‐functional celldetect® stain ⬇️

artículo científico publicado el 31 de mayo de 2011

Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?

artículo científico publicado en 2006

Sonographic appearance of uterine lymphoma: case report and review of the literature

artículo científico publicado en 2014

Sonographic diagnosis of uterine ewing sarcoma

scientific article published on 01 December 2009

Targeting IGF-1 signaling pathways in gynecologic malignancies

artículo científico

Targeting the IGF1 axis in cancer proliferation

artículo científico publicado en 2009

The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership

artículo científico publicado en 2015

The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches

artículo científico publicado en 2014

The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway ⬇️

artículo científico publicado el 8 de septiembre de 2011

The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies.

artículo científico publicado en 2018

The insulin-like growth factor-I receptor as an oncogene

scientific article published on May 2009

Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma

artículo científico publicado en 2004

Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience

artículo científico publicado en 2013

[Sling operations for treatment of stress incontinence in the woman. Expert correspondence update (replaces the October 2003 version)]

artículo científico publicado en 2006

p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy

artículo científico publicado en 2011

Lista de obras de

Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancer

Advancing women's cancer care. Report from the 37th Annual Meeting of the Society of Gynecologic Oncologists, Palm Springs, Calif., USA, March 22-26, 2006.

Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer

Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis

BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma

Basic and clinical significance of IGF-I-induced signatures in cancer

Carboplatin hypersensitivity: evaluation and successful desensitization protocol

Combination of endometrial thickness and time since menopause in predicting endometrial cancer in women with postmenopausal bleeding.

Contribution of sonographic measurement of ovarian volume to diagnosing ovarian tumors in postmenopausal women

Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.

Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma

Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action

Granulocytic sarcoma presenting as tumors of the cervix

High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent Ovarian Cancer-A Phase 2 Cohort Study

IGF-1 and BRCA1 signalling pathways in familial cancer

IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer

IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer

Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells.

Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines ⬇️

Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners

Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia ⬇️

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway

Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2.

Preoperative clinical and radiological features of metastatic ovarian tumors.

Proliferative and signaling activities of insulin analogues in endometrial cancer cells

Sarcoma post-embolization for presumed uterine fibroids

Screening for cervical neoplasia: A community‐based trial comparing Pap staining, human papilloma virus testing, and the new bi‐functional celldetect® stain ⬇️

Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?

Sonographic appearance of uterine lymphoma: case report and review of the literature

Sonographic diagnosis of uterine ewing sarcoma

Targeting IGF-1 signaling pathways in gynecologic malignancies

Targeting the IGF1 axis in cancer proliferation

The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership

The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches

The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway ⬇️

The Role of the Insulin-Like Growth Factor 1 Pathway in Immune Tumor Microenvironment and Its Clinical Ramifications in Gynecologic Malignancies.

The insulin-like growth factor-I receptor as an oncogene

Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma

Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience

[Sling operations for treatment of stress incontinence in the woman. Expert correspondence update (replaces the October 2003 version)]

p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy